文献速递关节外科

美国首个量产三维打印无骨水泥胫骨假体在美国关节置换登记系统中的中期表现

Mid-Term Performance of the First Mass-Produced Three-Dimensional Printed Cementless Tibia in the United States as Reported in the American Joint Replacement Registry.
PubMed 文献 · J Arthroplasty · 2022-08-05

基于美国关节置换登记系统(AJRR)2012年1月2日至2020年6月30日65岁及以上初次全膝关节置换病例,比较28,631例三维打印无骨水泥胫骨假体(3DTKA)与7,577例其他无骨水泥胫骨假体及550,133例骨水泥胫骨假体的中期存活率与翻修率;60个月时3DTKA的Kaplan-Meier假体存活率为98.9%,翻修率低于其他两组。

要点

  • 60个月假体存活率:3DTKA组98.9%(CI 98.7-99.0),其他无骨水泥组98.3%(CI 97.9-98.6),骨水泥组98.4%(CI 98.4-98.5)(P < .0001)。
  • 患者计时翻修率:3DTKA组3.11(CI 2.75-3.53)/1000年,其他无骨水泥组3.99(CI 3.34-4.76)/1000年,骨水泥组3.35(CI 3.28-3.42)/1000年。
  • 年翻修率:3DTKA组0.31%,其他无骨水泥组0.40%,骨水泥组0.34%。

核心结论

  • 在同一国家数据库同期植入的病例中,3DTKA相比其他无骨水泥骨水泥胫骨假体具有有利的存活率和更低的翻修率。

研究设计与样本

  • 回顾性查询美国关节置换登记系统(AJRR)2012年1月2日至2020年6月30日65岁及以上初次全膝关节置换病例,3DTKA组28,631例来自428家机构,其他无骨水泥胫骨假体组7,577例,骨水泥胫骨假体组550,133例,并与 Centers for Medicare & Medicaid Services 数据合并分析。

主要发现

  • 60个月Kaplan-Meier假体存活率:3DTKA组98.9%(CI 98.7-99.0),其他无骨水泥组98.3%(CI 97.9-98.6),骨水泥组98.4%(CI 98.4-98.5)(P < .0001)。
  • 患者计时翻修率:3DTKA组3.11(CI 2.75-3.53)/1000年,其他无骨水泥组3.99(CI 3.34-4.76)/1000年,骨水泥组3.35(CI 3.28-3.42)/1000年。
  • 年翻修率:3DTKA组0.31%,其他无骨水泥组0.40%,骨水泥组0.34%。

关键数值与推荐

  • 3DTKA组60个月假体存活率98.9%(CI 98.7-99.0),其他无骨水泥组98.3%(CI 97.9-98.6),骨水泥组98.4%(CI 98.4-98.5),P < .0001。
  • 3DTKA组患者计时翻修率3.11(CI 2.75-3.53)/1000年,其他无骨水泥组3.99(CI 3.34-4.76)/1000年,骨水泥组3.35(CI 3.28-3.42)/1000年。
  • 3DTKA组年翻修率0.31%,其他无骨水泥组0.40%,骨水泥组0.34%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cementless tibial components have shown improvements in clinical performance compared to predicate designs, though evidence supporting mid-term performance and fixation is scarce. The purpose of this study is to determine the mid-term survivorships, revision rates, and reasons why 3-dimensional printed cementless tibial baseplates (3DTKAs) failed compared to other cementless as well as cemented tibial baseplates reported from the American Joint Replacement Registry (AJRR) data. METHODS: All primary total knee arthroplasty (TKA) cases performed in patients 65 years of age or older within the AJRR from January 2, 2012 through June 30, 2020 were queried. A total of 28,631 3DTKAs were identified from 428 institutions. These were compared to all other "aggregated cementless tibia" (n = 7,577) and "aggregated cemented tibia" (n = 550,133) cases. Centers for Medicare & Medicaid Services data over the same time period were merged with AJRR data to determine survivorship and patient-timed incident revision rates per 1,000 years. Failure reasons were tracked during this study period. RESULTS: At 60 months, Kaplan-Meier implant survivorship was 98.9% (CI 98.7-99.0), 98.3% (CI 97.9-98.6), and 98.4% (CI 98.4-98.5) in the 3DTKA, aggregate cementless, and cemented knee cohorts, respectively (P < .0001). Patient-timed incident revision rates were 3.11 (CI 2.75-3.53), 3.99 (CI 3.34-4.76), and 3.35 (CI 3.28-3.42) for those cohorts, which corresponds to a revision rate of 0.31%, 0.40%, and 0.34% per year. CONCLUSION: In this analysis, 3DTKA had favorable survivorship and lower revision rates compared to aggregate cementless and cemented TKAs implanted from the same national database during the same time period.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Nam D, Bhowmik-Stoker M, Mahoney OM, et al. Mid-Term Performance of the First Mass-Produced Three-Dimensional Printed Cementless Tibia in the United States as Reported in the American Joint Replacement Registry. J Arthroplasty. 2022. PMID: 35934187. doi:10.1016/j.arth.2022.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。